Mr. Des Roches was born in New Orleans, Louisiana on August 12, 1966, and was admitted to the bar for the State of Louisiana in 1992. He has practiced continuously with Mr. Odom since 1992 and was made a partner in the firm in 1998. He is admitted to practice in numerous United States District Courts and Courts of Appeals throughout the country, as well as the United States Supreme Court. Mr. Des Roches was educated at the University of New Orleans (B.A., 1989), and Tulane University School of Law (J.D., 1992), and is a member of the New Orleans, Louisiana, and American Bar Associations.

The primary focus of Mr. Des Roches’ law practice throughout his career has been in the area of antitrust law. He has particular experience in antitrust litigation relating to the Hatch-Waxman Act and pharmaceutical industry, and has also been involved in antitrust cases involving medical devices, agricultural products, and certain segments of the steel industry. Mr. Des Roches served as the lead trial lawyer for the class of Sherman Act direct purchasers in In re Tricor Direct Purchaser Antitrust Litigation, which resulted in the largest settlement to date of a Hatch-Waxman antitrust case ($250,000,000) after commencement of trial. He also served as co-lead trial counsel with the firm’s partner Mr. Kelly in Natchitoches Parish Hospital Service District, et al. v. Tyco Healthcare, et al., which settled for $32,500,000 after three weeks of trial and on the eve of closing arguments. Mr. Des Roches has been actively involved in the following additional antitrust matters: In re Buspirone Antitrust Litig., MDL Docket No. 1410, S.D.N.Y. ($220,000,000 recovery); In re Cardizem CD Antitrust Litig., MDL Docket No. 1278, E.D.Mich. ($110,000,000 recovery); In re Relafen Antitrust Litig., Master File No. 01-12239, D. Mass. ($175,000,000 recovery); In re Terazosin Hydrochloride Antitrust Litig., MDL Docket No. 1317, S.D. Fla. ($72,500,000 recovery); In re Remeron Antitrust Litig., 03-CV-0085, D.N.J. ($75,000,000 recovery); In re K-Dur Antitrust Litig., MDL Docket No. 1419, D.N.J.; In re AndroGel Antitrust Litig., 09-md-2084 (TWT), N.D. Ga.; King Drug of Florence, Inc., et al. v. Cephalon, Inc., et al., 2:06-cv-01797 (MSG), E.D. Pa.

Mr. Des Roches has also been involved in various other business litigation matters, including numerous trials, representing interests of plaintiffs and defendants alike.